Public Health Europe - European Commission - EU

Coronavirus - COVID-19 (23.03.2020)

Check the EU’s response and ECDC’s assessment.

EUnetHTA’s response to the Covid-19 pandemic (16.09.2020)

EUnetHTA has recently published its first “rolling collaborative reviews” for 14 pharmaceutical and non-pharmaceutical (e.g. convalescent plasma) therapies available for COVID-19.

Coronavirus: Commission starts testing interoperability gateway service for national contact tracing and warning apps (14.09.2020)

To exploit fully the potential of mobile proximity contact tracing and warning apps to break the chain of coronavirus infections and save lives, the Commission is setting up an interoperability gateway service linking national apps across the EU.

SCHEER preliminary Opinion on the safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) - Hearing, 16 November 2020 (14.09.2020)

The preliminary Opinion will be open for public consultation from 26 October to 7 December 2020. Deadline for registration to the Hearing: 16 October 2020.

Health-EU Newsletter: Back-to-school may be different, but the EU’s commitment to giving kids a healthy start is the same (11.09.2020)

Interview of John F. Ryan, Director of Public Health, Country Knowledge and Crisis Management (European Commission - DG Health and Food Safety).

EU action on health

Improving health systems

Promoting good health

Medical devices

Substances of human origin

Blood, tissues, cells and organs

Pharmaceuticals

Diseases and health threats

Risk assessment

Scientific committees

Endocrine disruptors

Endocrine disruptors

Biocides

Biocides